Evidence map›Paper›PMID 37143714›Full record

ArticleBiochemia medica2023

Diagnosis of chylous abdominal effusions: what is the triglyceride threshold value?

Bertrand Lefrère, Emmanuel Curis, Randa Bittar, Antoine Levasseur, Pierre Grès, Zoé Guilbert, Belkacem Zenati, Corinne Cherfils, Mehdi Sakka, Dominique Bonnefont-Rousselot

Open access · diamondAbstract read
In one paragraph

Article in Biochemia medica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bertrand LefrèreMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Emmanuel CurisUR 7537 BioSTM, Faculty of Pharmacy Paris, Paris City University, Paris, France.
Randa BittarMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Antoine LevasseurMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Pierre GrèsMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Zoé GuilbertMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Belkacem ZenatiMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Corinne CherfilsMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Mehdi SakkaMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Dominique Bonnefont-RousselotMetabolic Biochemistry Department, Pitié-Salpêtrière University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France.
Sorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chylous abdominal effusions are serious complications that can be triggered by various aetiologies. The biochemical diagnosis of chyle leakage in ascites or in peritoneal fluid capsules relies on the detection of chylomicrons. Assaying the fluid's concentration of triglycerides is still the first-line tool. Given that only one comparative study has sought to quantify the value of the triglyceride assay for diagnosing chylous ascites in humans, our objective was to provide practical triglyceride thresholds. Materials and methods: We conducted a 9-year, retrospective, single-centre study of adult patients and compared a triglyceride assay with lipoprotein gel electrophoresis for the analysis of 90 non-recurring abdominal effusions (ascites and abdominal collections) of which 65 were chylous. Results: A triglyceride threshold of 0.4 mmol/L was associated with a sensitivity > 95%, and a threshold of 2.4 mmol/L was associated with a specificity > 95%. According to Youden index, the best threshold was 0.65 mmol/L with a sensitivity of 88 (77-95)%, a specificity of 72 (51-88)%, and, in our series, a positive predictive value of 89 (79-95)% and a negative predictive value of 69 (48-86)%. Conclusions: In our series, cut-off of 0.4 mmol/L could be used for ruling-out diagnosis of chylous effusions, while cut-off of 2.4 mmol/L could be used for reasonably confirming diagnosis.

Indexed as

AscitesChylous AscitesAdultAscitic FluidHumansRetrospective StudiesTriglyceridesTriglycerideschylous asciteslipoprotein gel electrophoresistriglycerides

Identifiers

PMID37143714
PMCPMC10152612
OpenAlexW4365143249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.